These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2999395)

  • 21. WF-10129, a novel angiotensin converting enzyme inhibitor produced by a fungus, Doratomyces putredinis.
    Ando T; Okada S; Uchida I; Hemmi K; Nishikawa M; Tsurumi Y; Fujie A; Yoshida K; Okuhara M
    J Antibiot (Tokyo); 1987 Apr; 40(4):468-75. PubMed ID: 3034846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives.
    Stanton JL; Watthey JW; Desai MN; Finn BM; Babiarz JE; Tomaselli HC
    J Med Chem; 1985 Nov; 28(11):1603-6. PubMed ID: 2999394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activity of carboxylic acid replacement analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline.
    Almquist RG; Chao WR; Jennings-White C
    J Med Chem; 1985 Aug; 28(8):1067-71. PubMed ID: 2991518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
    Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
    Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with an omega-aminoalkyl group.
    Saito S; Matsui S; Watanabe M; Waga T; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 Mar; 40(3):257-60. PubMed ID: 2346534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin converting enzyme inhibitors. 10. Aryl sulfonamide substituted N-[1-carboxy-3-phenylpropyl]-L-alanyl-L-proline derivatives as novel antihypertensives.
    Mencel JJ; Regan JR; Barton J; Menard PR; Bruno JG; Calvo RR; Kornberg BE; Schwab A; Neiss ES; Suh JT
    J Med Chem; 1990 Jun; 33(6):1606-15. PubMed ID: 2160536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and pharmacology of the potent angiotensin-converting enzyme inhibitor N-[1(S)-(ethoxycarbonyl)-3-phenylpropyl]-(S)-alanyl-(S)-pyroglutamic acid.
    Johnson AL; Price WA; Wong PC; Vavala RF; Stump JM
    J Med Chem; 1985 Nov; 28(11):1596-602. PubMed ID: 2999393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor.
    Ryan MJ; Boucher DM; Cohen DM; Essenburg AD; Major TC; Mertz TE; Olszewski BJ; Randolph AE; Singer RM; Kaplan HR
    J Pharmacol Exp Ther; 1984 Feb; 228(2):312-8. PubMed ID: 6319675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.
    Fournie-Zaluski MC; Coric P; Thery V; Gonzalez W; Meudal H; Turcaud S; Michel JB; Roques BP
    J Med Chem; 1996 Jun; 39(13):2594-608. PubMed ID: 8691458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acids.
    Blankley CJ; Kaltenbronn JS; DeJohn DE; Werner A; Bennett LR; Bobowski G; Krolls U; Johnson DR; Pearlman WM; Hoefle ML
    J Med Chem; 1987 Jun; 30(6):992-8. PubMed ID: 3035180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synthesis and biological activity of some Val(Ala)-Tyr and Val-Tyr-Tyr peptides].
    Chen PL; Peng SX; Yang ZX
    Yao Xue Xue Bao; 1992; 27(12):895-902. PubMed ID: 1299138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
    Baum T; Becker FT; Sybertz EJ
    Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human angiotensin I competes with two non-thiol converting enzyme inhibitors (CGS 13934 & MK-422) to inhibit the angiotensin-converting enzyme activity of human plasma.
    Chen DS; Nussberger J; Brunner HR; Waeber B
    J Pharm Pharmacol; 1984 Oct; 36(10):707-8. PubMed ID: 6150096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.
    Robl JA; Cimarusti MP; Simpkins LM; Brown B; Ryono DE; Bird JE; Asaad MM; Schaeffer TR; Trippodo NC
    J Med Chem; 1996 Jan; 39(2):494-502. PubMed ID: 8558518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin converting enzyme inhibitors: spirapril and related compounds.
    Smith EM; Swiss GF; Neustadt BR; McNamara P; Gold EH; Sybertz EJ; Baum T
    J Med Chem; 1989 Jul; 32(7):1600-6. PubMed ID: 2544729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketomethyldipeptides I. A new class of angiotensin converting enzyme inhibitors.
    Natarajan S; Gordon EM; Sabo EF; Godfrey JD; Weller HN; Pluscec J; Rom MB; Cushman DW
    Biochem Biophys Res Commun; 1984 Oct; 124(1):141-7. PubMed ID: 6093782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles.
    Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
    J Med Chem; 1993 Dec; 36(26):4230-8. PubMed ID: 8277505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.